Cargando…
A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats
Dopamine (DA) agonists are widely used as primary treatments for Parkinson's disease. However, they do not prevent progressive degeneration of dopaminergic neurons, the central pathology of the disease. In this study, we found that subcutaneous injection of a cytokine mixture containing granulo...
Autores principales: | Choudhury, Mohammed Emamussalehin, Sugimoto, Kana, Kubo, Madoka, Nagai, Masahiro, Nomoto, Masahiro, Takahashi, Hisaaki, Yano, Hajime, Tanaka, Junya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Inc
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217672/ https://www.ncbi.nlm.nih.gov/pubmed/22398979 http://dx.doi.org/10.1002/brb3.11 |
Ejemplares similares
-
Generation of CSF1-Independent Ramified Microglia-Like Cells from Leptomeninges In Vitro
por: Tanaka, Junya, et al.
Publicado: (2020) -
GM-CSF induces noninflammatory proliferation of microglia and disturbs electrical neuronal network rhythms in situ
por: Dikmen, Hasan Onur, et al.
Publicado: (2020) -
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
por: Ji Yuan, Wen, et al.
Publicado: (2008) -
Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats
por: Chattopadhyaya, I, et al.
Publicado: (2015) -
Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity
por: Huang, Chun, et al.
Publicado: (2018)